Effect of dipyridamole on vasodilator responses to ischemia, hypoxia, ATP, and AMP.
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000502:physiology* / Q000503:physiopathology*; D004176:Dipyridamole / Q000494:pharmacology*; D004285:Dogs; D005121:Extremities / Q000098:blood supply; D006940:Hyperemia / Q000503:physiopathology; D000860:Hypoxia / Q000503:physiopathology*; D007511:Ischemia / Q000503:physiopathology*; D012039:Regional Blood Flow / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects; D014666:Vasomotor System / Q000502:physiology* / Q000503:physiopathology*
D000227:Adenine Nucleotides; D004176:Dipyridamole; D000255:Adenosine Triphosphate